{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T15:43:18Z","timestamp":1788622998470,"version":"build-2803163510"},"reference-count":192,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T00:00:00Z","timestamp":1685491200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Dysfunctional hepatic metabolism has been linked to numerous diseases, including non-alcoholic fatty liver disease, the most common chronic liver disorder worldwide, which can progress to hepatic fibrosis, and is closely associated with insulin resistance and cardiovascular diseases. In addition, the liver secretes a wide array of metabolites, biomolecules, and microRNAs (miRNAs) and many of these secreted factors exert significant effects on metabolic processes both in the liver and in peripheral tissues. In this review, we summarize the involvement of liver-derived miRNAs in biological processes with an emphasis on delineating the communication between the liver and other tissues associated with metabolic disease progression. Furthermore, the review identifies the primary molecular targets by which miRNAs act. These consolidated findings from numerous studies provide insight into the underlying mechanism of various metabolic disease progression and suggest the possibility of using circulatory miRNAs as prognostic predictors and therapeutic targets for improving clinical intervention strategies.<\/jats:p>","DOI":"10.3390\/biomedicines11061597","type":"journal-article","created":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T03:59:35Z","timestamp":1685505575000},"page":"1597","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Insight into the Inter-Organ Crosstalk and Prognostic Role of Liver-Derived MicroRNAs in Metabolic Disease Progression"],"prefix":"10.3390","volume":"11","author":[{"given":"Bruno de Souza","family":"Goncalves","sequence":"first","affiliation":[{"name":"Department of Surgery and Biomedical Sciences, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25701, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avery","family":"Meadows","sequence":"additional","affiliation":[{"name":"Department of Surgery and Biomedical Sciences, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25701, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duane G.","family":"Pereira","sequence":"additional","affiliation":[{"name":"Department of Surgery and Biomedical Sciences, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25701, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghav","family":"Puri","sequence":"additional","affiliation":[{"name":"Department of Surgery and Biomedical Sciences, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25701, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5209-4836","authenticated-orcid":false,"given":"Sneha S.","family":"Pillai","sequence":"additional","affiliation":[{"name":"Department of Surgery and Biomedical Sciences, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25701, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,5,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Seto, W.K., and Mandell, M.S. (2021). Chronic liver disease: Global perspectives and future challenges to delivering quality health care. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0243607"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1564748","DOI":"10.1155\/2018\/1564748","article-title":"Systems and WBANs for Controlling Obesity","volume":"2018","author":"Mohammed","year":"2018","journal-title":"J. Healthc. Eng."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"756499","DOI":"10.3389\/fnmol.2021.756499","article-title":"A Review of miRNAs as Biomarkers and Effect of Dietary Modulation in Obesity Associated Cognitive Decline and Neurodegenerative Disorders","volume":"14","author":"Perdoncin","year":"2021","journal-title":"Front. Mol. Neurosci."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000318741","article-title":"Obesity affects the liver\u2014The link between adipocytes and hepatocytes","volume":"83","author":"Wree","year":"2011","journal-title":"Digestion"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/17474124.2018.1460202","article-title":"The relationship between obesity and the severity of non-alcoholic fatty liver disease: Systematic review and meta-analysis","volume":"12","author":"Lu","year":"2018","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/cld.807","article-title":"Obesity and Liver Decompensation","volume":"14","author":"Ahn","year":"2019","journal-title":"Clin. Liver Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0140-6736(16)30175-1","article-title":"Body-mass index and all-cause mortality: Individual-participant-data meta-analysis of 239 prospective studies in four continents","volume":"388","author":"Global","year":"2016","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics","volume":"92","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41580-018-0059-1","article-title":"Regulation of microRNA biogenesis and its crosstalk with other cellular pathways","volume":"20","author":"Treiber","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1093\/eurheartj\/ehw146","article-title":"Liver microRNAs: Potential mediators and biomarkers for metabolic and cardiovascular disease?","volume":"37","author":"Willeit","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"15079","DOI":"10.3748\/wjg.v20.i41.15079","article-title":"MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease","volume":"20","author":"Panera","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e1480","DOI":"10.1097\/MD.0000000000001480","article-title":"Epigenetic Modifications in the Biology of Nonalcoholic Fatty Liver Disease: The Role of DNA Hydroxymethylation and TET Proteins","volume":"94","author":"Pirola","year":"2015","journal-title":"Medicine"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Mc Cormack, B.A., Gonzalez-Canto, E., Agababyan, C., Espinoza-Sanchez, N.A., Tomas-Perez, S., Llueca, A., Mari-Alexandre, J., Gotte, M., and Gilabert-Estelles, J. (2021). miRNAs in the Era of Personalized Medicine: From Biomarkers to Therapeutics. Int. J. Mol. Sci.","DOI":"10.3390\/ijms22158154"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nrgastro.2013.87","article-title":"MicroRNAs in liver disease","volume":"10","author":"Szabo","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/gutjnl-2020-322526","article-title":"MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases","volume":"70","author":"Wang","year":"2021","journal-title":"Gut"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Schueller, F., Roy, S., Vucur, M., Trautwein, C., Luedde, T., and Roderburg, C. (2018). The Role of miRNAs in the Pathophysiology of Liver Diseases and Toxicity. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19010261"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Dongiovanni, P., Meroni, M., Longo, M., Fargion, S., and Fracanzani, A.L. (2018). miRNA Signature in NAFLD: A Turning Point for a Non-Invasive Diagnosis. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19123966"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"613","DOI":"10.4254\/wjh.v6.i8.613","article-title":"Circulating microRNAs in patients with non-alcoholic fatty liver disease","volume":"6","author":"Celikbilek","year":"2014","journal-title":"World J. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1530\/EJE-14-0867","article-title":"Elevated circulating microRNA-122 is associated with obesity and insulin resistance in young adults","volume":"172","author":"Wang","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13578-017-0161-7","article-title":"The roles of microRNA families in hepatic fibrosis","volume":"7","author":"Jiang","year":"2017","journal-title":"Cell Biosci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12272-018-01104-x","article-title":"Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma","volume":"42","author":"Heo","year":"2019","journal-title":"Arch. Pharmacal Res."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1093\/nar\/gkr254","article-title":"Characterization of extracellular circulating microRNA","volume":"39","author":"Turchinovich","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Hayes, C.N., and Chayama, K. (2016). MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17030280"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1136\/gutjnl-2018-318146","article-title":"miRNAs and NAFLD: From pathophysiology to therapy","volume":"68","author":"Gjorgjieva","year":"2019","journal-title":"Gut"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrgastro.2017.71","article-title":"Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets","volume":"14","author":"Szabo","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13578-019-0282-2","article-title":"Exosomes: Biogenesis, biologic function and clinical potential","volume":"9","author":"Zhang","year":"2019","journal-title":"Cell Biosci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00018-017-2595-9","article-title":"Current knowledge on exosome biogenesis and release","volume":"75","author":"Hessvik","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Prada, I., and Meldolesi, J. (2016). Binding and Fusion of Extracellular Vesicles to the Plasma Membrane of Their Cell Targets. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17081296"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"Raposo","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1021\/pr300152z","article-title":"miRNA and protein expression profiles of visceral adipose tissue reveal miR-141\/YWHAG and miR-520e\/RAB11A as two potential miRNA\/protein target pairs associated with severe obesity","volume":"11","author":"Capobianco","year":"2012","journal-title":"J. Proteome Res."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.trsl.2011.01.009","article-title":"Diabetes mellitus, a microRNA-related disease?","volume":"157","author":"Guay","year":"2011","journal-title":"Transl. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"100212","DOI":"10.1016\/j.aohep.2020.04.012","article-title":"Non-alcoholic fatty liver disease and microRNAs expression, how it affects the development and progression of the disease","volume":"21","author":"Uribe","year":"2021","journal-title":"Ann. Hepatol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"107683","DOI":"10.1016\/j.pharmthera.2020.107683","article-title":"Extracellular vesicles in hepatology: Physiological role, involvement in pathogenesis, and therapeutic opportunities","volume":"218","author":"Royo","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Becker, P.P., Rau, M., Schmitt, J., Malsch, C., Hammer, C., Bantel, H., Mullhaupt, B., and Geier, A. (2015). Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0142661"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/gutjnl-2014-306996","article-title":"Circulating microRNA signature in non-alcoholic fatty liver disease: From serum non-coding RNAs to liver histology and disease pathogenesis","volume":"64","author":"Pirola","year":"2015","journal-title":"Gut"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2013.05.021","article-title":"Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver","volume":"424","author":"Yamada","year":"2013","journal-title":"Clin. Chim. Acta"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"213","DOI":"10.15171\/mejdd.2018.113","article-title":"Role of MicroRNAs in Pathophysiology of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis","volume":"10","author":"Iravani","year":"2018","journal-title":"Middle East J. Dig. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","article-title":"miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting","volume":"3","author":"Esau","year":"2006","journal-title":"Cell Metab."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.gastro.2011.09.001","article-title":"A feedback loop between the liver-enriched transcription factor network and miR-122 controls hepatocyte differentiation","volume":"142","author":"Laudadio","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Cermelli, S., Ruggieri, A., Marrero, J.A., Ioannou, G.N., and Beretta, L. (2011). Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0023937"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"9844","DOI":"10.3748\/wjg.v22.i44.9844","article-title":"Disease-specific miR-34a as diagnostic marker of non-alcoholic steatohepatitis in a Chinese population","volume":"22","author":"Liu","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"108642","DOI":"10.1016\/j.abb.2020.108642","article-title":"miR-34a regulates lipid metabolism by targeting SIRT1 in non-alcoholic fatty liver disease with iron overload","volume":"695","author":"Wang","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jhep.2012.08.008","article-title":"miR-34a\/SIRT1\/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease","volume":"58","author":"Castro","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"13729","DOI":"10.1038\/srep13729","article-title":"Effect of miR-34a in regulating steatosis by targeting PPARalpha expression in nonalcoholic fatty liver disease","volume":"5","author":"Ding","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1038\/ncomms8466","article-title":"A metabolic stress-inducible miR-34a-HNF4alpha pathway regulates lipid and lipoprotein metabolism","volume":"6","author":"Xu","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1136\/gutjnl-2014-308883","article-title":"Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPARalpha expression","volume":"65","author":"Loyer","year":"2016","journal-title":"Gut"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Liu, J., Xiao, Y., Wu, X., Jiang, L., Yang, S., Ding, Z., Fang, Z., Hua, H., Kirby, M.S., and Shou, J. (2018). A circulating microRNA signature as noninvasive diagnostic and prognostic biomarkers for nonalcoholic steatohepatitis. BMC Genom., 19.","DOI":"10.1186\/s12864-018-4575-3"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1136\/gutjnl-2014-308430","article-title":"MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway","volume":"65","author":"Wu","year":"2016","journal-title":"Gut"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3892\/ijmm.2015.2076","article-title":"miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCR","volume":"35","author":"Sun","year":"2015","journal-title":"Int. J. Mol. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/mnfr.201200182","article-title":"Lycopene inhibits hepatic steatosis via microRNA-21-induced downregulation of fatty acid-binding protein 7 in mice fed a high-fat diet","volume":"56","author":"Ahn","year":"2012","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_54","first-page":"2201","article-title":"Role and mechanisms of action of microRNA-21 as regards the regulation of the WNT\/beta-catenin signaling pathway in the pathogenesis of non-alcoholic fatty liver disease","volume":"44","author":"Wang","year":"2019","journal-title":"Int. J. Mol. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1136\/gutjnl-2015-310822","article-title":"Stress-activated miR-21\/miR-21* in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption","volume":"65","author":"Calo","year":"2016","journal-title":"Gut"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.diabres.2012.11.025","article-title":"Upregulation of miR-15b in NAFLD models and in the serum of patients with fatty liver disease","volume":"99","author":"Zhang","year":"2013","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Pescador, N., Perez-Barba, M., Ibarra, J.M., Corbaton, A., Martinez-Larrad, M.T., and Serrano-Rios, M. (2013). Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0077251"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"119144","DOI":"10.1016\/j.lfs.2021.119144","article-title":"MiR-15b and miR-16 suppress TGF-beta1-induced proliferation and fibrogenesis by regulating LOXL1 in hepatic stellate cells","volume":"270","author":"Ma","year":"2021","journal-title":"Life Sci."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1039\/D0FO02286A","article-title":"The role of microRNA-33 as a key regulator in hepatic lipogenesis signaling and a potential serological biomarker for NAFLD with excessive dietary fructose consumption in C57BL\/6N mice","volume":"12","author":"Pan","year":"2021","journal-title":"Food Funct."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/liv.13109","article-title":"Hepatic miR-33a\/miR-144 and their target gene ABCA1 are associated with steatohepatitis in morbidly obese subjects","volume":"36","year":"2016","journal-title":"Liver Int."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1038\/ncomms3883","article-title":"MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice","volume":"4","author":"Horie","year":"2013","journal-title":"Nat. Commun."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/CIRCRESAHA.118.314415","article-title":"Specific Disruption of Abca1 Targeting Largely Mimics the Effects of miR-33 Knockout on Macrophage Cholesterol Efflux and Atherosclerotic Plaque Development","volume":"124","author":"Price","year":"2019","journal-title":"Circ. Res."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.1073\/pnas.1102281108","article-title":"miR-33a\/b contribute to the regulation of fatty acid metabolism and insulin signaling","volume":"108","author":"Davalos","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cellsig.2013.09.018","article-title":"Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells","volume":"26","author":"Li","year":"2014","journal-title":"Cell Signal."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1161\/CIRCRESAHA.121.320296","article-title":"Targeted Suppression of miRNA-33 Using pHLIP Improves Atherosclerosis Regression","volume":"131","author":"Zhang","year":"2022","journal-title":"Circ. Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/ATVBAHA.113.301732","article-title":"Therapeutic silencing of microRNA-33 inhibits the progression of atherosclerosis in Ldlr\u2212\/\u2212 mice\u2014Brief report","volume":"33","author":"Rotllan","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/1440-1681.12940","article-title":"Down-regulation of microRNA-375 regulates adipokines and inhibits inflammatory cytokines by targeting AdipoR2 in non-alcoholic fatty liver disease","volume":"45","author":"Lei","year":"2018","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.mce.2018.03.016","article-title":"MiR-451a attenuates free fatty acids-mediated hepatocyte steatosis by targeting the thyroid hormone responsive spot 14 gene","volume":"474","author":"Zeng","year":"2018","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1002\/jcb.26776","article-title":"MicroRNA-190b regulates lipid metabolism and insulin sensitivity by targeting IGF-1 and ADAMTS9 in non-alcoholic fatty liver disease","volume":"119","author":"Xu","year":"2018","journal-title":"J. Cell Biochem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.bbrc.2017.09.042","article-title":"MiR-181b regulates steatosis in nonalcoholic fatty liver disease via targeting SIRT1","volume":"493","author":"Wang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.bbrc.2018.12.061","article-title":"Upregulation of miR-181a impairs lipid metabolism by targeting PPARalpha expression in nonalcoholic fatty liver disease","volume":"508","author":"Huang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1900\/RDS.2015.12.260","article-title":"Beyond the Protein-Coding Sequence: Noncoding RNAs in the Pathogenesis of Type 2 Diabetes","volume":"12","author":"DiStefano","year":"2015","journal-title":"Rev. Diabet. Stud."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/cvr\/cvr300","article-title":"Role of microRNAs in diabetes and its cardiovascular complications","volume":"93","author":"Shantikumar","year":"2012","journal-title":"Cardiovasc. Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2337\/db16-0806","article-title":"Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis","volume":"66","author":"Skyler","year":"2017","journal-title":"Diabetes"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1159\/000430198","article-title":"MiR-499-5p Contributes to Hepatic Insulin Resistance by Suppressing PTEN","volume":"36","author":"Wang","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/hep4.1501","article-title":"Differential Associations of Circulating MicroRNAs With Pathogenic Factors in NAFLD","volume":"4","author":"Ezaz","year":"2020","journal-title":"Hepatol. Commun."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"527059","DOI":"10.3389\/fmed.2020.527059","article-title":"miRNA Dysregulation in the Development of Non-Alcoholic Fatty Liver Disease and the Related Disorders Type 2 Diabetes Mellitus and Cardiovascular Disease","volume":"7","author":"Escribano","year":"2020","journal-title":"Front. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2337\/db16-0731","article-title":"Circulating MicroRNA-122 Is Associated with the Risk of New-Onset Metabolic Syndrome and Type 2 Diabetes","volume":"66","author":"Willeit","year":"2017","journal-title":"Diabetes"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/cbin.11129","article-title":"Regulation of insulin resistance by targeting the insulin-like growth factor 1 receptor with microRNA-122-5p in hepatic cells","volume":"43","author":"Dong","year":"2019","journal-title":"Cell Biol. Int."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/oby.21950","article-title":"miRNA Signatures of Insulin Resistance in Obesity","volume":"25","author":"Jones","year":"2017","journal-title":"Obesity"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"5525112","DOI":"10.1155\/2021\/5525112","article-title":"MiR-122 Participates in Oxidative Stress and Apoptosis in STZ-Induced Pancreatic beta Cells by Regulating PI3K\/AKT Signaling Pathway","volume":"2021","author":"Wang","year":"2021","journal-title":"Int. J. Endocrinol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1053\/j.gastro.2020.05.056","article-title":"Agonist of RORA Attenuates Nonalcoholic Fatty Liver Progression in Mice via Up-regulation of MicroRNA 122","volume":"159","author":"Chai","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Mohany, K.M., Al Rugaie, O., Al-Wutayd, O., and Al-Nafeesah, A. (2021). Investigation of the levels of circulating miR-29a, miR-122, sestrin 2 and inflammatory markers in obese children with\/without type 2 diabetes: A case control study. BMC Endocr. Disord., 21.","DOI":"10.1186\/s12902-021-00829-z"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.gene.2019.02.096","article-title":"Long noncoding RNA Mirt2 upregulates USP10 expression to suppress hepatic steatosis by sponging miR-34a-5p","volume":"700","author":"Zhang","year":"2019","journal-title":"Gene"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00125-015-3783-5","article-title":"Role of microRNAs in the age-associated decline of pancreatic beta cell function in rat islets","volume":"59","author":"Tugay","year":"2016","journal-title":"Diabetologia"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/978-3-030-12668-1_7","article-title":"miRNA Regulation of Glucose and Lipid Metabolism in Relation to Diabetes and Non-alcoholic Fatty Liver Disease","volume":"1134","author":"Suksangrat","year":"2019","journal-title":"Rev. Biomark. Stud. Metab. Metab. Relat. Disord."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature11793","article-title":"Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b","volume":"494","author":"Kornfeld","year":"2013","journal-title":"Nature"},{"key":"ref_88","first-page":"2440","article-title":"MicroRNA-802 regulates hepatic insulin sensitivity and glucose metabolism","volume":"11","author":"Zhen","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1002\/oby.22932","article-title":"Hypertrophic Adipocyte-Derived Exosomal miR-802-5p Contributes to Insulin Resistance in Cardiac Myocytes through Targeting HSP60","volume":"28","author":"Wen","year":"2020","journal-title":"Obesity"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41467-020-15529-w","article-title":"Obesity-induced overexpression of miR-802 impairs insulin transcription and secretion","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.metabol.2014.12.003","article-title":"Identification of circulating miR-101, miR-375 and miR-802 as biomarkers for type 2 diabetes","volume":"64","author":"Higuchi","year":"2015","journal-title":"Metabolism"},{"key":"ref_92","first-page":"1230","article-title":"MicroRNA-802 increases hepatic oxidative stress and induces insulin resistance in high-fat fed mice","volume":"20","author":"Yang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Tao, H., Wang, M.M., Zhang, M., Zhang, S.P., Wang, C.H., Yuan, W.J., Sun, T., He, L.J., and Hu, Q.K. (2016). MiR-126 Suppresses the Glucose-Stimulated Proliferation via IRS-2 in INS-1 beta Cells. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0149954"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.2337\/db11-1508","article-title":"Adipose tissue microRNAs as regulators of CCL2 production in human obesity","volume":"61","author":"Arner","year":"2012","journal-title":"Diabetes"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/CIRCRESAHA.110.226357","article-title":"Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes","volume":"107","author":"Zampetaki","year":"2010","journal-title":"Circ. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"761617","DOI":"10.1155\/2013\/761617","article-title":"Plasma miR-126 is a potential biomarker for early prediction of type 2 diabetes mellitus in susceptible individuals","volume":"2013","author":"Zhang","year":"2013","journal-title":"Biomed Res. Int."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.beem.2016.08.001","article-title":"Circulating microRNAs as biomarkers for metabolic disease","volume":"30","author":"Parrizas","year":"2016","journal-title":"Best Pr. Res. Clin. Endocrinol. Metab."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Liang, T., Liu, C., and Ye, Z. (2013). Deep sequencing of small RNA repertoires in mice reveals metabolic disorders-associated hepatic miRNAs. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0080774"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ncb2211","article-title":"Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism","volume":"13","author":"Jordan","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"7981","DOI":"10.1021\/acs.jafc.2c02940","article-title":"miR-143-Mediated Responses to Betaine Supplement Repress Lipogenesis and Hepatic Gluconeogenesis by Targeting MAT1a and MAPK11","volume":"70","author":"Chen","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.trsl.2018.09.006","article-title":"Circulating miR-143-3p inhibition protects against insulin resistance in Metabolic Syndrome via targeting of the insulin-like growth factor 2 receptor","volume":"205","author":"Xihua","year":"2019","journal-title":"Transl. Res."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1111\/liv.14067","article-title":"MicroRNA-30b regulates insulin sensitivity by targeting SERCA2b in non-alcoholic fatty liver disease","volume":"39","author":"Dai","year":"2019","journal-title":"Liver Int."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/labinvest.2015.112","article-title":"miR-101a and miR-30b contribute to inflammatory cytokine-mediated beta-cell dysfunction","volume":"95","author":"Zheng","year":"2015","journal-title":"Lab. Investig."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12944-020-01261-3","article-title":"MiR-30b-5p regulates the lipid metabolism by targeting PPARGC1A in Huh-7 cell line","volume":"19","author":"Zhang","year":"2020","journal-title":"Lipids Health Dis."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.7150\/thno.23334","article-title":"Circulating ectosomes: Determination of angiogenic microRNAs in type 2 diabetes","volume":"8","author":"Stepien","year":"2018","journal-title":"Theranostics"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/ijo.2017.21","article-title":"Decreased lipid metabolism but increased FA biosynthesis are coupled with changes in liver microRNAs in obese subjects with NAFLD","volume":"41","author":"Latorre","year":"2017","journal-title":"Int. J. Obes."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/jdi.13396","article-title":"Micro-ribonucleic acid-23a-3p prevents the onset of type 2 diabetes mellitus by suppressing the activation of nucleotide-binding oligomerization-like receptor family pyrin domain containing 3 inflammatory bodies-caused pyroptosis through negatively regulating NIMA-related kinase 7","volume":"12","author":"Chang","year":"2021","journal-title":"J. Diabetes Investig."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00592-014-0617-8","article-title":"Serum miR-23a, a potential biomarker for diagnosis of pre-diabetes and type 2 diabetes","volume":"51","author":"Yang","year":"2014","journal-title":"Acta Diabetol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1530\/JME-20-0324","article-title":"miR-23a\/b-3p promotes hepatic lipid accumulation by regulating Srebp-1c and Fas","volume":"68","author":"Li","year":"2021","journal-title":"J. Mol. Endocrinol."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2337\/db16-0592","article-title":"MicroRNAs miR-23a-3p, miR-23b-3p, and miR-149-5p Regulate the Expression of Proapoptotic BH3-Only Proteins DP5 and PUMA in Human Pancreatic beta-Cells","volume":"66","author":"Grieco","year":"2017","journal-title":"Diabetes"},{"key":"ref_111","doi-asserted-by":"crossref","unstructured":"de Candia, P., Spinetti, G., Specchia, C., Sangalli, E., La Sala, L., Uccellatore, A., Lupini, S., Genovese, S., Matarese, G., and Ceriello, A. (2017). A unique plasma microRNA profile defines type 2 diabetes progression. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0188980"},{"key":"ref_112","first-page":"14","article-title":"miRNA-15a, miRNA-15b, and miRNA-499 are Reduced in Erythrocytes of Pre-Diabetic African-American Adults","volume":"2","author":"Fluitt","year":"2016","journal-title":"Jacobs J. Diabetes Endocrinol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/nature10112","article-title":"MicroRNAs 103 and 107 regulate insulin sensitivity","volume":"474","author":"Trajkovski","year":"2011","journal-title":"Nature"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"511","DOI":"10.3748\/wjg.v21.i2.511","article-title":"miRNA-103: Molecular link between insulin resistance and nonalcoholic fatty liver disease","volume":"21","author":"Xu","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Simoniene, D., Stukas, D., Dauksa, A., and Velickiene, D. (2022). Clinical Role of Serum miR107 in Type 2 Diabetes and Related Risk Factors. Biomolecules.","DOI":"10.3390\/biom12040558"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3389\/fphys.2015.00209","article-title":"The role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosis","volume":"6","author":"Lambrecht","year":"2015","journal-title":"Front. Physiol."},{"key":"ref_117","first-page":"304","article-title":"Liver Fibrosis: Causes and Methods of Assessment, A Review","volume":"53","author":"Toosi","year":"2015","journal-title":"Rom. J. Intern. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.cellsig.2012.07.023","article-title":"The potential of microRNAs in liver fibrosis","volume":"24","author":"He","year":"2012","journal-title":"Cell. Signal."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.1111\/jcmm.15212","article-title":"GRHL2 induces liver fibrosis and intestinal mucosal barrier dysfunction in non-alcoholic fatty liver disease via microRNA-200 and the MAPK pathway","volume":"24","author":"Wang","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"2670658","DOI":"10.1155\/2017\/2670658","article-title":"miR-200c Accelerates Hepatic Stellate Cell-Induced Liver Fibrosis via Targeting the FOG2\/PI3K Pathway","volume":"2017","author":"Ma","year":"2017","journal-title":"Biomed Res. Int."},{"key":"ref_121","doi-asserted-by":"crossref","unstructured":"Murakami, Y., Toyoda, H., Tanaka, M., Kuroda, M., Harada, Y., Matsuda, F., Tajima, A., Kosaka, N., Ochiya, T., and Shimotohno, K. (2011). The progression of liver fibrosis is related with overexpression of the miR-199 and 200 families. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0016081"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"9583932","DOI":"10.1155\/2021\/9583932","article-title":"Integrated MicroRNA Expression Profile Reveals Dysregulated miR-20a-5p and miR-200a-3p in Liver Fibrosis","volume":"2021","author":"Ye","year":"2021","journal-title":"Biomed Res. Int."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1111\/jcmm.13278","article-title":"MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy","volume":"21","author":"Chen","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/1751-2980.12266","article-title":"miR-30c and miR-193 are a part of the TGF-beta-dependent regulatory network controlling extracellular matrix genes in liver fibrosis","volume":"16","author":"Roy","year":"2015","journal-title":"J. Dig. Dis."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000488411","article-title":"MicroRNA-30a Suppresses the Activation of Hepatic Stellate Cells by Inhibiting Epithelial-to-Mesenchymal Transition","volume":"46","author":"Zheng","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1053\/j.gastro.2011.12.044","article-title":"Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues","volume":"142","author":"Rozenfeld","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1159\/000363005","article-title":"Depletion of thymosin beta4 promotes the proliferation, migration, and activation of human hepatic stellate cells","volume":"34","author":"Xiao","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.1002\/jcp.30097","article-title":"Thymoquinone alleviates liver fibrosis via miR-30a-mediated epithelial-mesenchymal transition","volume":"236","author":"Geng","year":"2020","journal-title":"J. Cell Physiol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cellsig.2017.07.016","article-title":"MicroRNA-146a-5p attenuates liver fibrosis by suppressing profibrogenic effects of TGFbeta1 and lipopolysaccharide","volume":"39","author":"Zou","year":"2017","journal-title":"Cell. Signal."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.cellsig.2012.06.003","article-title":"MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4","volume":"24","author":"He","year":"2012","journal-title":"Cell Signal."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"16163","DOI":"10.1038\/srep16163","article-title":"MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a","volume":"5","author":"Du","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_132","first-page":"147","article-title":"Using Next-generation Sequencing to Identify Novel Exosomal miRNAs as Biomarkers for Significant Hepatic Fibrosis","volume":"31","author":"Wang","year":"2021","journal-title":"Discov. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1073\/pnas.0605298103","article-title":"NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses","volume":"103","author":"Taganov","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1667\/RR15401.1","article-title":"MicroRNA-146a-5p Attenuates Fibrosis-related Molecules in Irradiated and TGF-beta1-Treated Human Hepatic Stellate Cells by Regulating PTPRA-SRC Signaling","volume":"192","author":"Yuan","year":"2019","journal-title":"Radiat. Res."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3349\/ymj.2019.60.6.561","article-title":"miR-140-3p Knockdown Suppresses Cell Proliferation and Fibrogenesis in Hepatic Stellate Cells via PTEN-Mediated AKT\/mTOR Signaling","volume":"60","author":"Wu","year":"2019","journal-title":"Yonsei Med. J."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.1111\/j.1742-4658.2009.07213.x","article-title":"Changes in microRNAs associated with hepatic stellate cell activation status identify signaling pathways","volume":"276","author":"Guo","year":"2009","journal-title":"FEBS J."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.19082\/1804","article-title":"Circulating miRNAs as Predictor Markers for Activation of Hepatic Stellate Cells and Progression of HCV-Induced Liver Fibrosis","volume":"8","author":"Nagy","year":"2016","journal-title":"Electron. Physician"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.12659\/MSM.894000","article-title":"MicroRNA-34a Promotes Hepatic Stellate Cell Activation via Targeting ACSL1","volume":"21","author":"Yan","year":"2015","journal-title":"Med. Sci. Monit."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"615","DOI":"10.7150\/ijms.51589","article-title":"MiR-34c promotes hepatic stellate cell activation and Liver Fibrogenesis by suppressing ACSL1 expression","volume":"18","author":"Li","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.21037\/atm-21-5005","article-title":"MiR-34a promotes fibrosis of hepatic stellate cells via the TGF-beta pathway","volume":"9","author":"Zhang","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"ref_141","doi-asserted-by":"crossref","unstructured":"Tian, X.F., Ji, F.J., Zang, H.L., and Cao, H. (2016). Activation of the miR-34a\/SIRT1\/p53 Signaling Pathway Contributes to the Progress of Liver Fibrosis via Inducing Apoptosis in Hepatocytes but Not in HSCs. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0158657"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.23922","article-title":"Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis","volume":"53","author":"Roderburg","year":"2011","journal-title":"Hepatology"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"7325","DOI":"10.18632\/oncotarget.2621","article-title":"microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K\/AKT pathway","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/path.4373","article-title":"MicroRNA-101 suppresses liver fibrosis by targeting the TGFbeta signalling pathway","volume":"234","author":"Tu","year":"2014","journal-title":"J. Pathol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.1080\/15384101.2015.1120917","article-title":"MALAT1 functions as a competing endogenous RNA to mediate Rac1 expression by sequestering miR-101b in liver fibrosis","volume":"14","author":"Yu","year":"2015","journal-title":"Cell Cycle"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/CIRCRESAHA.122.321253","article-title":"Gut Microbially Produced Indole-3-Propionic Acid Inhibits Atherosclerosis by Promoting Reverse Cholesterol Transport and Its Deficiency Is Causally Related to Atherosclerotic Cardiovascular Disease","volume":"131","author":"Xue","year":"2022","journal-title":"Circ. Res."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"101610","DOI":"10.1016\/j.arr.2022.101610","article-title":"Noncoding RNAs in age-related cardiovascular diseases","volume":"77","author":"Jusic","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"ref_148","first-page":"e25495","article-title":"Nonalcoholic Fatty Liver Disease: An Emerging Modern-Day Risk Factor for Cardiovascular Disease","volume":"14","author":"Hassen","year":"2022","journal-title":"Cureus"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1055\/a-1930-6658","article-title":"Shared Mechanisms between Cardiovascular Disease and NAFLD","volume":"42","author":"Huang","year":"2022","journal-title":"Semin. Liver Dis."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"847849","DOI":"10.1155\/2012\/847849","article-title":"MicroRNA Regulation of Cholesterol Metabolism","volume":"2012","author":"Rotllan","year":"2012","journal-title":"Cholesterol"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nature04303","article-title":"Silencing of microRNAs in vivo with \u2018antagomirs\u2019","volume":"438","author":"Krutzfeldt","year":"2005","journal-title":"Nature"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1053\/j.gastro.2017.08.013","article-title":"Metabolic Circuit Involving Free Fatty Acids, microRNA 122, and Triglyceride Synthesis in Liver and Muscle Tissues","volume":"153","author":"Chai","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1042\/CS20130203","article-title":"MicroRNAs in the onset and development of cardiovascular disease","volume":"126","author":"Vickers","year":"2014","journal-title":"Clin. Sci."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1476-511X-11-55","article-title":"Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease","volume":"11","author":"Gao","year":"2012","journal-title":"Lipids Health Dis."},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Li, X., Yang, Y., Wang, L., Qiao, S., Lu, X., Wu, Y., Xu, B., Li, H., and Gu, D. (2015). Plasma miR-122 and miR-3149 Potentially Novel Biomarkers for Acute Coronary Syndrome. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0125430"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"5326","DOI":"10.1111\/jcmm.16544","article-title":"Cardiac-specific overexpression of miR-122 induces mitochondria-dependent cardiomyocyte apoptosis and promotes heart failure by inhibiting Hand2","volume":"25","author":"Shi","year":"2021","journal-title":"J. Cell. Mol. Med."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1126\/science.1189123","article-title":"MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis","volume":"328","author":"Kristo","year":"2010","journal-title":"Science"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"e003376","DOI":"10.1161\/JAHA.112.003376","article-title":"MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE\u2212\/\u2212 mice","volume":"1","author":"Horie","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.celrep.2017.10.023","article-title":"Genetic Dissection of the Impact of miR-33a and miR-33b during the Progression of Atherosclerosis","volume":"21","author":"Price","year":"2017","journal-title":"Cell Rep."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1126\/science.1189862","article-title":"MiR-33 contributes to the regulation of cholesterol homeostasis","volume":"328","author":"Rayner","year":"2010","journal-title":"Science"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCRESAHA.117.305624","article-title":"Macrophage Mitochondrial Energy Status Regulates Cholesterol Efflux and Is Enhanced by Anti-miR33 in Atherosclerosis","volume":"117","author":"Karunakaran","year":"2015","journal-title":"Circ. Res."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/1354750X.2018.1501760","article-title":"Circulating miRNA-33: A potential biomarker in patients with coronary artery disease","volume":"24","author":"Reddy","year":"2019","journal-title":"Biomarkers"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1161\/CIRCRESAHA.112.300648","article-title":"MicroRNA-144 regulates hepatic ATP binding cassette transporter A1 and plasma high-density lipoprotein after activation of the nuclear receptor farnesoid X receptor","volume":"112","author":"Tarling","year":"2013","journal-title":"Circ. Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1161\/CIRCRESAHA.112.300626","article-title":"Control of cholesterol metabolism and plasma high-density lipoprotein levels by microRNA-144","volume":"112","author":"Ramirez","year":"2013","journal-title":"Circ. Res."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"eaaw9709","DOI":"10.1126\/scitranslmed.aaw9709","article-title":"Liver macrophages inhibit the endogenous antioxidant response in obesity-associated insulin resistance","volume":"12","author":"Azzimato","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1053\/j.gastro.2021.08.030","article-title":"Hepatic miR-144 Drives Fumarase Activity Preventing NRF2 Activation During Obesity","volume":"161","author":"Azzimato","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1161\/ATVBAHA.119.313633","article-title":"MicroRNA-144 Silencing Protects Against Atherosclerosis in Male, but Not Female Mice","volume":"40","author":"Cheng","year":"2020","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_168","doi-asserted-by":"crossref","unstructured":"Hu, Y.W., Hu, Y.R., Zhao, J.Y., Li, S.F., Ma, X., Wu, S.G., Lu, J.B., Qiu, Y.R., Sha, Y.H., and Wang, Y.C. (2014). An agomir of miR-144-3p accelerates plaque formation through impairing reverse cholesterol transport and promoting pro-inflammatory cytokine production. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0094997"},{"key":"ref_169","first-page":"440","article-title":"Altered Plasma miR-144 as a Novel Biomarker for Coronary Artery Disease","volume":"48","author":"Chen","year":"2018","journal-title":"Ann. Clin. Lab. Sci."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"610561","DOI":"10.3389\/fcvm.2020.610561","article-title":"MiR-223-3p in Cardiovascular Diseases: A Biomarker and Potential Therapeutic Target","volume":"7","author":"Zhang","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"14518","DOI":"10.1073\/pnas.1215767111","article-title":"MicroRNA-223 coordinates cholesterol homeostasis","volume":"111","author":"Vickers","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1093\/eurheartj\/ehv713","article-title":"A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223","volume":"37","author":"Wang","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"e000745","DOI":"10.1161\/JAHA.112.000745","article-title":"Tissue- and plasma-specific MicroRNA signatures for atherosclerotic abdominal aortic aneurysm","volume":"1","author":"Kin","year":"2012","journal-title":"J. Am. Heart Assoc."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3389\/fmed.2019.00280","article-title":"Hypertension Associated with Hyperlipidemia Induced Different MicroRNA Expression Profiles in Plasma, Platelets, and Platelet-Derived Microvesicles; Effects of Endothelial Progenitor Cell Therapy","volume":"6","author":"Alexandru","year":"2019","journal-title":"Front. Med."},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Wijnen, W.J., van der Made, I., van den Oever, S., Hiller, M., de Boer, B.A., Picavet, D.I., Chatzispyrou, I.A., Houtkooper, R.H., Tijsen, A.J., and Hagoort, J. (2014). Cardiomyocyte-specific miRNA-30c over-expression causes dilated cardiomyopathy. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0096290"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1042\/BJ20101585","article-title":"Involvement of miR-30c and miR-301a in immediate induction of plasminogen activator inhibitor-1 by placental growth factor in human pulmonary endothelial cells","volume":"434","author":"Patel","year":"2011","journal-title":"Biochem. J."},{"key":"ref_177","doi-asserted-by":"crossref","unstructured":"Li, J., Donath, S., Li, Y., Qin, D., Prabhakar, B.S., and Li, P. (2010). miR-30 regulates mitochondrial fission through targeting p53 and the dynamin-related protein-1 pathway. PLoS Genet., 6.","DOI":"10.1371\/annotation\/4050116d-8daa-4b5a-99e9-34cdd13f6a26"},{"key":"ref_178","first-page":"807","article-title":"microRNA-30c negatively regulates endometrial cancer cells by targeting metastasis-associated gene-1","volume":"27","author":"Zhou","year":"2012","journal-title":"Oncol. Rep."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nm.3200","article-title":"MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion","volume":"19","author":"Soh","year":"2013","journal-title":"Nat. Med."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1743-7075-10-56","article-title":"Supplementary site interactions are critical for the regulation of microsomal triglyceride transfer protein by microRNA-30c","volume":"10","author":"Soh","year":"2013","journal-title":"Nutr. Metab."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"117092","DOI":"10.1016\/j.lfs.2019.117092","article-title":"Circulating miR-30c as a predictive biomarker of type 2 diabetes mellitus with coronary heart disease by regulating PAI-1\/VN interactions","volume":"239","author":"Luo","year":"2019","journal-title":"Life Sci."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"8889195","DOI":"10.1155\/2021\/8889195","article-title":"Downregulation of miR-128 Ameliorates Ang II-Induced Cardiac Remodeling via SIRT1\/PIK3R1 Multiple Targets","volume":"2021","author":"Zhan","year":"2021","journal-title":"Oxidative Med. Cell. Longev."},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Newman, L.A., Useckaite, Z., Johnson, J., Sorich, M.J., Hopkins, A.M., and Rowland, A. (2022). Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease. Biomedicines.","DOI":"10.3390\/biomedicines10010195"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/15476278.2021.2020018","article-title":"Upregulation of miR-128 Mediates Heart Injury by Activating Wnt\/beta-catenin Signaling Pathway in Heart Failure Mice","volume":"17","author":"Li","year":"2021","journal-title":"Organogenesis"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"e780","DOI":"10.1038\/cddis.2013.301","article-title":"Pro-apoptotic miRNA-128-2 modulates ABCA1, ABCG1 and RXRalpha expression and cholesterol homeostasis","volume":"4","author":"Adlakha","year":"2013","journal-title":"Cell Death Dis."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/nm.3949","article-title":"MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels","volume":"21","author":"Goedeke","year":"2015","journal-title":"Nat. Med."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nm.3980","article-title":"Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis","volume":"21","author":"Wagschal","year":"2015","journal-title":"Nat. Med."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jcjd.2020.12.005","article-title":"Circulating miR-148a-5p and miR-21-5p as Novel Diagnostic Biomarkers in Adult Egyptian Male Patients with Metabolic Syndrome","volume":"45","author":"Doghish","year":"2021","journal-title":"Can. J. Diabetes"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"113419","DOI":"10.1016\/j.biopha.2022.113419","article-title":"Antagonism of miR-148a attenuates atherosclerosis progression in APOB(TG)Apobec(\u2212\/\u2212)Ldlr(+\/\u2212) mice: A brief report","volume":"153","author":"Rotllan","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"e000096","DOI":"10.1136\/bmjgast-2016-000096","article-title":"Circulating miRNA in patients with non-alcoholic fatty liver disease and coronary artery disease","volume":"3","author":"Mehta","year":"2016","journal-title":"BMJ Open Gastroenterol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nature08195","article-title":"miR-145 and miR-143 regulate smooth muscle cell fate and plasticity","volume":"460","author":"Cordes","year":"2009","journal-title":"Nature"},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1002\/hep.27153","article-title":"Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia","volume":"60","author":"Ng","year":"2014","journal-title":"Hepatology"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/6\/1597\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:45:55Z","timestamp":1760125555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/6\/1597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,31]]},"references-count":192,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["biomedicines11061597"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines11061597","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,31]]}}}